Archives
-
LY2886721: A Precision BACE Inhibitor Roadmap
2026-08-19
A translational framework for using LY2886721 to investigate BACE1 biology, amyloid beta reduction, synaptic safety, and exposure-aware study design in Alzheimer’s disease research.
-
FAK Inhibitor 14: Applied Research Workflows
2026-08-19
FAK Inhibitor 14 enables controlled dissection of FAK-driven adhesion, migration, and EMT in cancer models. This practical guide connects reagent handling with cholesterol-resistance experiments, pathway-focused controls, and troubleshooting strategies for reproducible cell migration inhibition.
-
Bacitracin (B1670): Lab Protocol Guide
2026-08-18
Bacitracin (B1670) provides a research reagent for studying bacterial growth inhibition associated with cell wall and peptidoglycan synthesis disruption. It is intended for controlled antibacterial research workflows only and should not be used for diagnostic, clinical, or medical applications.
-
Bovine Ovarian Heterogeneity, Redox Stress, and Apoptosis
2026-08-18
This study shows that simple morphology-based classification of bovine ovaries corresponds to coordinated redox imbalance and apoptotic activation in ovarian tissue, follicular fluid, and granulosa cells. Its cross-compartment design identifies granulosa cells as the most sensitive functional readout and offers a practical strategy for reducing biological variability in cattle assisted reproductive technology studies.
-
4-Hydroxytamoxifen: Protocol Parameters and QC
2026-08-17
4-Hydroxytamoxifen provides a DMSO-compatible estrogen receptor modulator for controlled cell, cardiac myocyte, and cancer research workflows. It should not be selected for protocols that require water or ethanol dissolution, and solution storage should be minimized to protect reproducibility.
-
GSTA1, Glutathione Depletion, and α-Amanitin Injury
2026-08-17
A 2026 study identifies GSTA1 as an unexpected driver rather than a protective factor in α-amanitin-induced hepatotoxicity. By combining mouse toxicology, multi-omics, binding assays, and genetic perturbation, the authors connect NRF2-associated GSTA1 induction with glutathione depletion, ROS accumulation, and hepatocyte death.
-
CGP 55845 hydrochloride for Synaptic Assays
2026-08-16
Use CGP 55845 hydrochloride as a high-affinity pharmacological tool to separate GABAB receptor signaling from astrocytic GAT-3 effects in electrophysiology and neurotransmitter-release experiments. This guide connects product pharmacology with dentate gyrus workflows, practical controls, concentration planning, and troubleshooting.
-
Troxerutin, TRPM7, and Diabetic Cognitive Dysfunction
2026-08-15
The reference study identifies a TRPM7–calcineurin–Drp1Ser637 pathway that links calcium dysregulation to mitochondrial fission, neuronal apoptosis, and diabetic cognitive dysfunction. Using diabetic mice and high-glucose hippocampal neurons, the authors show that troxerutin suppresses this pathway and improves mitochondrial and behavioral outcomes, while also highlighting important limits for translation.
-
CUDC-907: Practical Protocol and QC Guide
2026-08-14
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis. This guide uses product-dossier specifications and workflow recommendations; it is not a clinical, diagnostic, or therapeutic protocol.
-
Imatinib hydrochloride Research Workflows
2026-08-14
Build more informative kinase experiments with Imatinib hydrochloride, from dose–response studies to pathway-resolved validation in CML and GIST models. This guide combines practical assay design with a conformational signaling insight that helps distinguish direct kinase blockade from downstream phosphatase effects.
-
3-Deazaadenosine: A Translational Methylation Lens
2026-08-13
3-Deazaadenosine offers researchers a mechanistically distinctive way to perturb methylation flux through S-adenosylhomocysteine hydrolase inhibition. This article connects its biochemical rationale to METTL14-dependent inflammation research, preclinical antiviral research, experimental design, and translational decision-making without overstating clinical maturity.
-
Cy5 Hydrazide for Carbonyl-Resolved Nanoparticle Assays
2026-08-13
Cy5 hydrazide enables sensitive carbonyl-reactive fluorescent dye labeling of proteins, glycoproteins, oligonucleotides, and nanoparticle interfaces. This guide focuses on assay design, controls, and interpretation rather than simply describing nanoparticle preparation.
-
Ferrostatin-1: A Translational Lens on Glioma Cell Death
2026-08-12
Ferrostatin-1 (Fer-1) is more than a ferroptosis inhibitor: it is a mechanistic control for separating iron-dependent lipid peroxidation from emerging death programs such as cuproptosis. This thought-leadership perspective connects glioma molecular subtyping with practical ferroptosis assay design, translational decision-making, and responsible interpretation across cancer biology research and neurodegenerative disease models.
-
Astrocytic GAT-3 in Dentate Gyrus Synaptic Plasticity
2026-08-12
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than solely a GABA-clearance transporter. By linking GAT-3 activity to astrocytic Ca2+ signaling, presynaptic GluN2B-containing NMDARs, and contextual fear memory, it provides a mechanistic framework for studying glia-dependent hippocampal plasticity.
-
FH1: A Maturity-First Strategy for iHep Assays
2026-08-11
FH1 small molecule B3700 supports more functional iPS-derived hepatocyte-like cells through improved albumin secretion, CYP3A4 expression, morphology, and reduced AFP. This article presents an assay-centered framework for interpreting FH1 maturation data alongside light-controlled gene regulation research.